Etsy Inc vs BIO-TECHNE Corp — how do they compare? Etsy Inc trades at $79.73 (market cap $7.38B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Etsy Inc pays none. Which is the better fit depends on your goals.
| ETSY | TECH | |
|---|---|---|
Market Cap | $7.38B | $11.24B |
Sector | Consumer Cyclical | Health |
52-Week High | $86.47 | $72.29 |
52-Week Low | $44.05 | $43.31 |
Enterprise Value | $9.33B | $11.32B |
Dividend Yield | — | 0.44% |
Signals from Pluang's Aura AI — not financial advice
ETSY trades at $85.55, up 4.0% over 24 hours, with a bullish technical signal and consistent earnings beats in recent quarters. The company reported Q2 2026 EPS of $0.98, exceeding expectations, and announced a $2 billion share repurchase program alongside a 12% workforce reduction to boost efficiency. Revenue growth remains stable at $2.9 billion for 2026, though net income margins have moderated from prior years.
Outlook is positive with raised 2026 guidance and AI-driven marketplace improvements, but risks include high debt levels and competitive pressures. Analysts are evenly split between Buy and Hold ratings, with a consensus price target of $85.71, suggesting limited near-term upside from current levels.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Trailing returns across standard periods
Latest headlines on both assets
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →